Sheng Ma

Elevated FOXA1 Expression Indicates Poor Prognosis in Liver Cancer due to Its Effects on Cell Proliferation and Metastasis

T. Xiao, Yaru Wang, Zhenrong Liu, 2022, Disease markers.

GAS1RR, an immune-related enhancer RNA, is related to biochemical recurrence-free survival in prostate cancer

Z. Ye, Baolong Qin, Yue Ge, 2022, Experimental biology and medicine.

A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma

Bei Li, Yue Ge, Bo Liu, 2023, PeerJ.

Metabolic classifications of renal cell carcinoma reveal intrinsic connections with clinical and immune characteristics

Zhiquan Hu, Jun Xiao, Yue Ge, 2023, Journal of Translational Medicine.

UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer

Y. Xun, Peng Zhou, Hai-feng Zhou, 2023, The Journal of clinical investigation.

Autophagy and biotransformation affect sorafenib resistance in hepatocellular carcinoma

W. Ying, W. Rong, Jianping Xu, 2023, Computational and structural biotechnology journal.

Targeting Alpha‐Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD‐1 Blockade Immunotherapy in Renal Cell Carcinoma

Baojun Wang, Zhiquan Hu, Gong-Hong Wei, 2023, Advanced science.

Integrating bioinformatic analysis and detailed experiments reveal an EMT‐related biomarker for clear cell renal cell carcinoma

Bei Li, Bo Liu, Zezhong Xiong, 2023, Cancer medicine.